HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.

AbstractBACKGROUND:
The apolipoprotein A5 gene (APOA5) -1131 T > C polymorphism is associated with mild hypertriglyceridemia in type 2 diabetic subjects, and interacts with dietary fat in the determination of triglyceride concentrations. We examined whether a substitution of whole grains and legumes for refined rice in a high carbohydrate diet (about 65% of energy derived from carbohydrate) may modify the effect of this variant on changes in apolipoprotein A-V (apoA-V) and triglyceride concentrations.
METHODS:
We genotyped the APOA5 -1131 T > C in individuals with impaired fasting glucose (IFG) or newly diagnosed type 2 diabetes, who were randomly assigned to either a group ingesting whole grain and legume meals daily or a control group for 12 weeks.
RESULTS:
After dietary intervention, we observed significant interactions between the APOA5 -1131 T > C polymorphism and carbohydrate sources (whole grains and legumes versus refined rice) in the determination of mean percent changes in triglyceride and apoA-V (P interactions <0.001 and =0.038, respectively). In the refined rice group (n = 93), the carriers of the risk C allele (n = 50) showed a greater increase in the mean percent changes of triglyceride and apoA-V than noncarriers after adjusting for HOMA-IR (P = 0.004 and 0.021, respectively). The whole grain and legume group (n = 92), however, showed a decrease in fasting glucose, HOMA-IR, and triglyceride, and an increase in apoA-V, irrespective of genotype.
CONCLUSIONS:
The data showed that the magnitude of the genetic effect of the APOA5 -1131C variant on triglyceride and apoA-V levels was modulated when substituting consumption of whole grains and legumes for refined rice as a carbohydrate source in IFG or diabetic subjects.
TRIAL REGISTRATION:
ClinicalTrials.gov: NCT01784952.
AuthorsRyungwoo Kang, Minjoo Kim, Jey Sook Chae, Sang-Hyun Lee, Jong Ho Lee
JournalTrials (Trials) Vol. 15 Pg. 100 (Apr 01 2014) ISSN: 1745-6215 [Electronic] England
PMID24690159 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • APOA5 protein, human
  • Apolipoprotein A-V
  • Apolipoproteins A
  • Biomarkers
  • Blood Glucose
  • Dietary Carbohydrates
  • Insulin
  • Triglycerides
Topics
  • Apolipoprotein A-V
  • Apolipoproteins A (blood, genetics)
  • Biomarkers (blood)
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 2 (blood, diagnosis, diet therapy, genetics)
  • Dietary Carbohydrates (adverse effects)
  • Edible Grain
  • Fabaceae
  • Fasting (blood)
  • Female
  • Genotype
  • Humans
  • Insulin (blood)
  • Male
  • Middle Aged
  • Oryza
  • Phenotype
  • Polymorphism, Genetic
  • Republic of Korea
  • Time Factors
  • Treatment Outcome
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: